Endeavor

Moffitt Experts Share Discoveries Driving Innovation in Cancer Immunotherapy

The Society for Immunotherapy of Cancer brings together industry leaders to highlight new research and clinical applications in immunotherapy

AI Helps Predict Treatment Response in Melanoma

Identifying and analyzing immune cells under the microscope can help personalize therapies

Moffitt Hosts Inaugural Cell Coast Conference to Spotlight Breakthroughs in Cellular Immunotherapy

Experts discuss the latest advances in CAR T, TIL and TCR therapies

Experimental Vaccine Gives Young Mother a Shot at Cure

A dendritic cell vaccine changes young mother’s prognosis and landscape for breast cancer treatments

New Trial Reveals Key Timing in Immunotherapy for Small Cell Lung Cancer

Adding immunotherapy after chemo-radiation may boost survival, but not during treatment

Moffitt Study Shows Promising Results for Treating Aggressive Prostate Cancer with Immunotherapy

New phase 2 trial explores adding nivolumab into combination treatment for advanced disease

AACR Cancer Progress Report Reveals Breakthroughs and Barriers

New therapies and research drive progress against cancer, but there’s still work to be done

Triplet Therapy Shows Promise in Advanced Lung Cancer

EVOKE-02 study marks an innovative and unconventional approach

Moffitt Celebrates Proton Therapy Unit Milestone at Speros

The topping out moment marks a major moment in Pasco campus’s construction